Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management.
Ali FawazOmar Abdel-RahmanPublished in: Cancer management and research (2022)
Though progress has been made, the optimal management of BR-PDAC is uncertain. Phase III trials utilizing modern chemotherapeutic regimens are needed to establish a standard of care.